$TARA 4/A SEC Filings

Filed On	Filing
19 May 2025	Form 4/A: Levy Richard S, Director Bought 20,000 shares ($63.8K)
28 Mar 2025	Form 4/A: Fabbio Patrick, Chief Financial Officer Holds 42,439 shares of Common Stock
28 Mar 2025	Form 4/A: Shefferman Jesse, Director Holds 978,553 shares of Common Stock
28 Mar 2025	Form 4/A: Fry Hannah, VP, Controller Holds 36,812 shares of Common Stock
28 Mar 2025	Form 4/A: Zummo Jacqueline, Chf Scientific Operations Off Holds 120,085 shares of Common Stock
15 Apr 2022	Form 4/A: Opaleye Management Inc., 10% owner Bought 2,345 shares ($11.1K) · Bought 7,791 shares ($37.4K)
09 Mar 2022	Form 4/A: Bandari Jathin, Chief Medical Officer Holds 21,000 shares of Common Stock
11 Jun 2020	Form 4/A: Solomon Michael Edward, Director Granted 9,537 Stock Option (Right to Buy) · Received 26,500 shares as a grant or award
11 Jun 2020	Form 4/A: Garceau Roger, Director Granted 12,399 Stock Option (Right to Buy)
11 Jun 2020	Form 4/A: Braunstein Scott, Director Granted 34,716 Stock Option (Right to Buy)
11 Jun 2020	Form 4/A: Beshar Luke M, Director Granted 19,075 Stock Option (Right to Buy)
18 Feb 2020	Form 4/A: Shefferman Jesse, Director Granted 111,250 Stock Option (Right to Buy)
30 Jun 2017	Form 4/A: Tvm Life Science Ventures Vi GmbH & Co Kg, Director and 4 others Acquired 372 Series A Convertible Preferred Stock (Open Market Purchase) ($372K)

Comments